NYSE:ELAN Elanco Animal Health (ELAN) Stock Price, News & Analysis $26.32 -0.38 (-1.44%) Closing price 11/19/2026 03:59 PM EasternExtended Trading$26.05 -0.26 (-1.00%) As of 08:31 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Elanco Animal Health Stock (NYSE:ELAN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Elanco Animal Health alerts:Sign Up Key Stats Today's Range$26.29▼$27.4950-Day Range$21.78▼$26.8252-Week Range$19.40▼$27.98Volume7.05 million shsAverage Volume5.43 million shsMarket Capitalization$13.15 billionP/E RatioN/ADividend YieldN/APrice Target$30.36Consensus RatingModerate Buy Company Overview Elanco Animal Health is a global animal health company that develops, manufactures and markets products for companion animals and livestock. Its offerings include medicines, vaccines and other products intended to prevent and treat disease and support animal health. For pets, Elanco provides treatments for conditions including parasitic infections, pain and chronic diseases. Its livestock products support the health of animals such as cattle, poultry, swine and fish, serving producers and veterinarians. The company traces its origins to Eli Lilly’s animal health business, established in 1954, and became an independent public company in 2018. Elanco serves customers in markets around the world and expanded its portfolio through the acquisition of Bayer Animal Health in 2020.AI Generated. May Contain Errors. Read More Elanco Animal Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks57th Percentile Overall ScoreELAN MarketRank™: 2.84613267272 of 5 starsElanco Animal Health scored higher than 57% of companies evaluated by MarketBeat, and ranked 382nd out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingModerate Buy Consensus RatingElanco Animal Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 9 buy ratings, 2 hold ratings, and 1 sell rating.Upside PotentialElanco Animal Health has a consensus price target of $30.36, representing about 15.4% upside from its current price of $26.32.Amount of Analyst CoverageElanco Animal Health has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Elanco Animal Health's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth9.32% Earnings GrowthEarnings for Elanco Animal Health are expected to grow by 9.32% in the coming year, from $1.18 to $1.29 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Elanco Animal Health is -87.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Elanco Animal Health is -87.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioElanco Animal Health has a PEG Ratio of 2.26. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioElanco Animal Health has a P/B Ratio of 1.98. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted6.67% of the float of Elanco Animal Health has been sold short.Short Interest Ratio / Days to CoverElanco Animal Health has a short interest ratio ("days to cover") of 7.18.Change versus previous monthShort interest in Elanco Animal Health has recently increased by 5.84%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldElanco Animal Health does not currently pay a dividend.Dividend GrowthElanco Animal Health does not have a long track record of dividend growth. News and Social Media2.2 / 5News Sentiment0.48 News SentimentElanco Animal Health has a news sentiment score of 0.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 10 news articles for Elanco Animal Health this week, compared to 5 articles on an average week.Search InterestOnly 2 people have searched for ELAN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Elanco Animal Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership2.9 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $835,950.00 in company stock, which represents 0.0064% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Elanco Animal Health insiders have bought 835.53% more of their company's stock than they have sold. Specifically, they have bought $936,000.00 in company stock and sold $100,050.00 in company stock.Percentage Held by Insiders1.14% of the stock of Elanco Animal Health is held by insiders.Percentage Held by Institutions97.48% of the stock of Elanco Animal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Elanco Animal Health's insider trading history. Receive ELAN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Elanco Animal Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ELAN Stock News HeadlinesAnalysts Offer Insights on Healthcare Companies: Privia Health Group (PRVA) and Elanco Animal Health (ELAN)38 minutes ago | theglobeandmail.comA look back at pharmaceuticals stocks’ Q3 earnings: Elanco vs the rest of the packNovember 19 at 3:04 PM | theglobeandmail.comUnder 3 cents a nightBill Poulos's Black Friday deal: a full year of the Instant Scanner for $7, one payment. The regular price is $247, about a dollar a night. With roughly 250 trading nights a year, that's 2.8 cents a night to have nearly a thousand of America's biggest stocks checked, with exact buy prices on whatever qualifies. No re-bills and nothing to install. At $7, the only question is whether you get around to it.November 20 at 1:00 AM | Profits Run (Ad)Elanco Animal Health Incorporated announces an Equity Buyback for $600 million worth of its shares.November 19 at 3:04 PM | marketscreener.comMElanco Announces Inaugural $600 Million Share Repurchase AuthorizationNovember 19 at 6:27 AM | prnewswire.comElanco to Participate in Upcoming Investor ConferencesNovember 18 at 8:22 AM | prnewswire.comElanco Animal Health Incorporated (ELAN) - What Are Analysts Thinking About This Stock?November 16, 2026 | americanbankingnews.comStifel Nicolaus Sticks to Its Buy Rating for Elanco Animal Health (ELAN)November 12, 2026 | theglobeandmail.comSee More Headlines ELAN Stock Analysis - Frequently Asked Questions How have ELAN shares performed this year? Elanco Animal Health's stock was trading at $22.64 on January 1st, 2026. Since then, ELAN shares have increased by 16.2% and is now trading at $26.3160. How were Elanco Animal Health's earnings last quarter? Elanco Animal Health Incorporated (NYSE:ELAN) announced its earnings results on Friday, November, 6th. The company reported $0.27 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.07. Elanco Animal Health's revenue was up 11.3% compared to the same quarter last year. Read the conference call transcript. How will Elanco Animal Health's stock buyback program work? Elanco Animal Health's board approved a stock repurchase plan on Thursday, November 19th 2026, which authorizes the company to buy back $600 million in outstanding shares, according to EventVestor. This means that the company could buy up to 4.5% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's leadership believes its shares are undervalued. When did Elanco Animal Health IPO? Elanco Animal Health (ELAN) raised $1.4 billion in an initial public offering (IPO) on Thursday, September 20th 2018. The company issued 62,900,000 shares at $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Barclays, BNP PARIBAS, BofA Merrill Lynch, Citigroup, Credit Suisse, Deutsche Bank Securities, Evercore ISI, Cowen, Academy Securities, Drexel Hamilton, Mischler Financial Group, Ramirez and The Williams Capital Group were co-managers. Who are Elanco Animal Health's major shareholders? Top institutional shareholders of Elanco Animal Health include Dodge & Cox (12.29%), State Street Corp (3.26%), Marshall Wace LLP (2.01%) and Artemis Investment Management LLP (0.92%). Insiders that own company stock include Lawrence Erik Kurzius, R David Hoover, Jeffrey N Simmons, Rajeev A Modi, Timothy J Bettington, Robert M Vanhimbergen, Michael J Harrington, Paul Herendeen and Shiv O'neill. View institutional ownership trends. How do I buy shares of Elanco Animal Health? Shares of ELAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Elanco Animal Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Elanco Animal Health investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Salesforce (CRM), Pfizer (PFE), Merck & Co., Inc. (MRK), Palo Alto Networks (PANW) and CrowdStrike (CRWD). Company Calendar Last Earnings11/06/2026Today11/20/20269th Annual Evercore ISI HealthCONx Conference11/30/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 ELAN's financial health is in the Green zone, according to TradeSmith. ELAN has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNYSE:ELAN CIK1739104 Webwww.elanco.com Phone(877) 352-6261FaxN/AEmployees9,400Year Founded1954Price Target and Rating Average Price Target for Elanco Animal Health$30.36 High Price Target$35.00 Low Price Target$24.00 Potential Upside/Downside+15.4%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage12 Analysts Profitability EPS (Trailing Twelve Months)($0.30) Trailing P/E RatioN/A Forward P/E Ratio20.40 P/E Growth2.26Net Income-$232 million Net Margins-2.86% Pretax Margin-1.79% Return on Equity8.80% Return on Assets4.32% Debt Debt-to-Equity Ratio0.55 Current Ratio2.09 Quick Ratio1.07 Sales & Book Value Annual Sales$4.72 billion Price / Sales2.79 Cash Flow$2.29 per share Price / Cash Flow11.51 Book Value$13.26 per share Price / Book1.98Miscellaneous Outstanding Shares499,830,000Free Float494,129,000Market Cap$13.15 billion OptionableOptionable Beta1.73 Social Links 7 Energy Stocks to Buy and Hold ForeverOil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.Get This Free Report This page (NYSE:ELAN) was last updated on 11/19/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredYour father's savings lost half their value after 1971.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredA Bill Would Reprice America's Gold at Market ValueThe US government still values its gold at $42 an ounce, a price Congress set in 1973. Gold trades above $4,00...Concord Gold Capital | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elanco Animal Health Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Elanco Animal Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.